個股熱度排行 | 4月21日港股盤前
根據uSMART輿情監測數據，從20日晚間到21日港股盤前時間段，市場關注指數最高的5只股票是理想汽車-W、復星醫藥、國藥控股、亞洲聯網科技、君實生物。
4月21日—港股關注排行TOP5
理想汽車-W
關注度第一爲理想汽車-W，該股上個交易日收盤下跌2.58%，報於98.20港元。近5個交易日累計上漲1.39%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
理想汽車：疫情影響4月生產 正積極恢復產能
江浙滬供應鏈無法供貨 理想汽車：4月部分新車交付將延遲
復星醫藥
關注度第二爲復星醫藥，該股上個交易日收盤上漲1.69%，報於33.15港元。近5個交易日累計下跌5.01%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
復星醫藥：漢斯狀®聯合HLX07和漢貝泰®用於一線治療不可切除或轉移性肝細胞癌獲批內地臨牀試驗
復星醫藥控股子公司獲藥品臨牀試驗批準
國藥控股
關注度第三爲國藥控股，該股上個交易日收盤下跌1.15%，報於17.22港元。近5個交易日累計下跌2.60%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
國藥附屬國藥器械首季賺2.1億人民幣 倒退1.8%
國藥控股：國藥器械首季營業利潤5.13億元 同比增長2.28%
亞洲聯網科技
關注度第四爲亞洲聯網科技，該股上個交易日收盤下跌2.75%，報於1.06港元。近5個交易日累計下跌1.85%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
亞洲聯網科技：於公開市場出售合共171.6萬股農行股份
亞洲聯網科技斥5012.9萬元收購債券
君實生物
關注度第五爲君實生物，該股上個交易日收盤下跌5.26%，報於51.30港元。近5個交易日累計上漲5.34%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
君實生物聘任鄒建軍爲副總經理兼全球研發總裁
君實生物提名鄒建軍爲執行董事候選人
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
